BACKGROUND: Although there are many psoriasis assessment tools currently published,
one of the unmet needs in psoriasis research remains consensus about the single best …

Objectives While off-label dosing of biologic treatments may be necessary in selected
psoriasis patients, no systematic review exists to date that synthesizes the efficacy and …

European S3-Guidelines on the systemic treatment of psoriasis vulgaris D Pathirana, AD
Ormerod, P Saiag, C Smith, PI Spuls, A Na Page 1 JEADV october 2009, volume 23 …

BACKGROUND: The prevalence of obesity is rapidly increasing in the United States.
Patients with psoriasis, in particular, tend to be above normal weight. Three of the 5 …

Objective To evaluate the efficacy and safety of alefacept in combination with methotrexate
(MTX) for the treatment of psoriatic arthritis (PsA). Methods Patients were eligible for this …

Objectives To analyze the current total cost of systemic therapy for psoriasis and to compare
annual trends in the cost of both generic and brand-name therapies with trends in the …

The time necessary for a treatment to become effective is crucial for patients and physicians
but has been largely neglected in the reporting and comparison of clinical trials in …

Psoriasis is a common inflammatory disease of the skin and joints. Its etiology remains
unknown, however, it has been linked to complex interactions between predisposing genes …

Purpose Advances in the treatment of moderate-to-severe plaque psoriasis, including new
biological agents and related drugs, are reviewed. Summary Most patients with psoriasis …

Background Psoriasis is frequently seen in older patients, and systemic treatment is often
indicated. Randomized controlled trials (RCTs) generally maintain strict inclusion and …